TARDBP and neurodegenerative disease: Their phenotypes are likely to change under a different genetic background, as shown before for several other genetically modified neurodegenerative disease mouse models, e.g. the transgenic AD mouse model 5xFAD (database, by Jackson Lab) and the mice carrying TDP-43 mutations induced by ENU [26].